more

Moderna (MRNA)

(Real Time Quote from BATS)

$123.79 USD

+0.97 (0.79%)

Updated Jul 12, 2024 11:42 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank	Definition	Annualized Return
1	Strong Buy	24.15%
2	Buy	17.88%
3	Hold	9.47%
4	Sell	5.14%
5	Strong Sell	2.57%
S&P	500	11.11%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5 2

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score	A
Growth Score	A
Momentum Score	A
VGM Score	A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

F Value F Growth B Momentum F VGM

Industry Rank:

Top 28% (71 out of 250)

Industry: Medical - Biomedical and Genetics

View All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

The Zacks Analyst Blog Highlights: Buckle, Chipotle Mexican Grill, Co-Diagnostics, Moderna and Regeneron Pharmaceuticals

by Zacks Equity Research Published on March 11,2020

The Zacks Analyst Blog Highlights: Buckle, Chipotle Mexican Grill, Co-Diagnostics, Moderna and Regeneron Pharmaceuticals

medical

5 Stocks to Win Big From Trump's Economic Stimulus

by Tirthankar Chakraborty Published on March 10,2020

Trump floats financial aids to counter the impact of the coronavirus outbreak. Notable stimulus measures include payroll tax cut, aid for wage earners and an emergency funding worth $8.3 billion

LabCorp (LH) Launches Test to Detect Presence of Coronavirus

by Zacks Equity Research Published on March 09,2020

LabCorp (LH), with an aim to contain the outbreak of coronavirus, launches the LabCorp 2019 Novel Coronavirus (COVID-19), NAA test.

medical

The Zacks Analyst Blog Highlights: Moderna, Inovio Pharmaceuticals, Vir Biotechnology and Alnylam Pharmaceuticals

by Zacks Equity Research Published on March 06,2020

The Zacks Analyst Blog Highlights: Moderna, Inovio Pharmaceuticals, Vir Biotechnology and Alnylam Pharmaceuticals

medical

Regeneron (REGN) Gains from Focus on Coronavirus Treatments

by Zacks Equity Research Published on March 05,2020

Regeneron's (REGN) shares grow year to date owing to focus on developing a treatment for combating the novel coronavirus.

House Okays $8 Billion Funds to Combat COVID-19: 3 Winners

by Manaswita Ghosh Dutta Published on March 05,2020

U.S. lawmakers' deal to find a vaccine for tackling the coronavirus stands to benefit the healthcare industry.

medical

3 Correction-Defying Bets to Buy as Markets Brave Coronavirus

by Manaswita Ghosh Dutta Published on March 04,2020

Global markets lost $6 trillion in the week ended Feb 29 as coronavirus triggered sharp selloff. Here's how to play the dip.

medical

5 Drug Makers to Gain From Coronavirus Outbreak

by Zacks Equity Research Published on March 04,2020

Drug makers globally are working on developing therapies and vaccines for coronavirus. Here are five stocks that are currently in focus.

4 Top Stocks to Win Big From the Coronavirus Pandemic (Revised)

by Tirthankar Chakraborty Published on March 04,2020

Professional money managers are looking to buy stocks that act as a hedge against coronavirus threat, or those that simply benefits from the particular event.

Trump Asks Pharma Firms to Step Up Coronavirus Vaccine Work

by Kinjel Shah Published on March 03,2020

President Donald Trump asks pharmaceutical companies working on making vaccines or treatments for coronavirus to accelerate development.

Best & Worst Performing Stocks in Coronavirus Outbreak

by Tirthankar Chakraborty Published on March 03,2020

Here're the big winners and losers since the coronavirus outbreak brought the U.S. bull market to a standstill.

The Zacks Analyst Blog Highlights: Moderna, Inovio Pharmaceuticals, Co-Diagnostics and Apple

by Zacks Equity Research Published on March 03,2020

The Zacks Analyst Blog Highlights: Moderna, Inovio Pharmaceuticals, Co-Diagnostics and Apple

Is the Options Market Predicting a Spike in Moderna (MRNA) Stock?

by Zacks Equity Research Published on March 02,2020

Investors need to pay close attention to Moderna (MRNA) stock based on the movements in the options market lately.

MRNAPositive Net Change

medical

5 Biotechs That Escaped the Coronavirus Onslaught Last Week

by Kinjel Shah Published on March 02,2020

Here we discuss 5 biotech stocks that outperformed the industry amid the U.S. market slump.

biotechs

4 Top Stocks to Win Big From the Coronavirus Pandemic

by Tirthankar Chakraborty Published on March 02,2020

Professional money managers are looking to buy stocks that act as a hedge against coronavirus threat, or those that simply benefits from the particular event.